Oxygen consumption in Plasmodium berghei-infected murine red cells: a direct spectrophotometric assay in intact erythrocytes.
A spectrophotometric assay has been devised to measure oxygen consumption non-invasively in intact murine red cells parasitized by Plasmodium berghei. The method uses oxyhemoglobin in the erythrocytes both as a source of oxygen and as an indicator of oxygen consumption. Spectra of intact cells show broad peaks and sloping baselines due to light-scattering. In order to ascertain the number of varying components in the 370-450 nm range, the resolution of the spectra was enhanced using Fourier transforms of the frequency domain spectra. Calculation of oxygen consumption was carried out for two-component systems (oxyhemoglobin, deoxyhemoglobin) using absorbances at 415 and 431 nm. Samples prepared from highly parasitized mice (greater than 80% parasitemia, 5% hematocrit) showed oxygen consumption rates of (4-8) X 10(-8) microliter/cell per h. This rate was not attributable to the presence of white cells or reticulocytes. The rate of oxygen consumption in the erythrocytes is shown to be modulated by various agents: the respiratory inhibitors NaN3 and KCN (1 mM) reduced oxygen consumption 2-3-fold; salicylhydroxamic acid (2.5 mM) caused a 20% reduction in rate and 10 mM NaN3, completely blocked deoxygenation. Antimalarial drugs and metal-chelating agents were also tested. Chloroquine, EDTA and desferal (desferoxamine mesylate) did not decrease the deoxygenation rate of hemoglobin in parasitized cells. Quinacrine, quinine and primaquine reduced the rate of formation of deoxyhemoglobin but also produced substantial quantities of methemoglobin. The lipophilic chelator, 5-hydroxyquinoline, decreased the rate of deoxygenation one-third. The spectrophotometric assay provides a convenient means to monitor oxygen consumption in parasitized red cells, to test the effects of various agents thereon, and potentially to explore possible mechanisms for oxygen utilization.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D004912:Erythrocytes / Q000469:parasitology; D008288:Malaria / Q000097:blood*; D008297:Male; D051379:Mice; D010101:Oxygen Consumption / Q000187:drug effects; D010108:Oxyhemoglobins / Q000032:analysis; D010962:Plasmodium berghei / Q000378:metabolism*; D011190:Potassium Cyanide / Q000494:pharmacology; D051381:Rats; D019810:Sodium Azide; D013053:Spectrophotometry; D013997:Time Factors
D000962:Antimalarials; D001386:Azides; D002614:Chelating Agents; D010108:Oxyhemoglobins; D019810:Sodium Azide; D011190:Potassium Cyanide